Sign In
Buy BAYRY
$13.89
-0.110 (-0.786%)
At Close: Jul 31, 2026
Bayer wins fourth Roundup weedkiller case in U.S
03:12am, Saturday, 18'th Jun 2022
A U.S. jury found Bayer's Roundup weedkiller did not cause an Oregon man's cancer, the German agriculture and pharmaceuticals company said on Saturday, handing the firm its fourth consecutive trial vi
U.S. Supreme Court takes no action on Bayer bid to nix weedkiller suits
09:43am, Monday, 13'th Jun 2022
The U.S. Supreme Court on Monday took no action on Bayer AG's bid to dismiss legal claims by customers who contend its Roundup weedkiller causes cancer as the German company seeks to avoid potentially
U.S. Supreme Court will soon decide whether to hear Bayer's weedkiller case
01:07am, Friday, 10'th Jun 2022
The U.S. Supreme Court could announce as soon as Monday whether it will hear Bayer's bid to dismiss claims its Roundup weedkiller causes cancer as the company seeks to avoid potentially billions of do
7 Blue-Chip Stocks to Buy Now if You Have $250 to Spend
06:08am, Wednesday, 08'th Jun 2022
These seven blue-chip stocks are trading at relative bargains and they can all be added to your portfolio for less than $250. The post 7 Blue-Chip Stocks to Buy Now if You Have $250 to Spend appeared
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond
08:05am, Thursday, 26'th May 2022
These three healthcare stocks should hold their value for years.
Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
06:54am, Friday, 20'th May 2022
Atara Biotherapeutics Inc (NASDAQ: ATRA) received notification that Bayer AG's (OTC: BAYRY) intends to end the exclusive worldwide licensing agreement for mesothelin-directed CAR T-cell therapies
Bayer shares plunge after U.S. Justice Department asks Supreme Court to reject Roundup appeal
05:49am, Wednesday, 11'th May 2022
Shares in Bayer AG fell in opening trade on Wednesday after a U.S. Justice department brief recommended that the Supreme Court reject a company appeal to review a case linking its Roundup weedkiller t
Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q1 2022 Results - Earnings Call Transcript
12:57pm, Tuesday, 10'th May 2022
Bayer Aktiengesellschaft (OTCPK:BAYZF) Q1 2022 Results Conference Call May 10, 2022 8:00 AM ET Company Participants Oliver Maier - Head, IR Werner Baumann - CEO Wolfgang Nickl - CFO Rodrigo Santos - P
Bayer says Ukraine farmers progress with planting despite war
09:35am, Tuesday, 10'th May 2022
Farmers in Ukraine have made better-than-expected progress preparing their fields so far despite Russia's attack on the country, the world's largest supplier of seeds and crop chemicals, Bayer, said o
Bayer's farming business drives Q1 earnings beat
01:48am, Tuesday, 10'th May 2022
Agriculture and pharmaceuticals company Bayer reported quarterly adjusted core earnings rose a better-than-expected 27.5% on strong gains at its seeds and pesticides business.
Bayer gets shareholder rebuke for management remuneration
12:51pm, Friday, 29'th Apr 2022
Shareholders of Bayer on Friday voted to reprimand the German drug and farming supplies maker for its top management pay scheme, after one leading proxy advisory group said it did not adequately refle
Bayer says start to the year very successful thanks to agriculture unit
12:12pm, Monday, 25'th Apr 2022
German diversified group Bayer has seen a "very successful start to the year", driven by a favourable environment in agricultural markets, it said on Monday.
Norway's sovereign fund will vote to support Bayer management
05:29am, Sunday, 24'th Apr 2022
Norway's $1.3 trillion wealth fund will cast a vote in support next week of top management at German drug and farm products maker Bayer AG, but will vote against the remuneration package of CEO Werner
AbbVie and Bayer Record Hefty Share Price Gains in 1st Quarter
05:57pm, Thursday, 21'st Apr 2022
Two health care companies most investors might not be familiar with were among the four biggest stock market gainers in the first quarter, according to an analysis by Evaluate.
Bayer: Still A Buy
05:19pm, Thursday, 07'th Apr 2022
Bayer's technical picture improved in the last few months, and the company also reported solid fiscal 2021 results.
